We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $3.18B
1-Year Est. Return 65.92%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+65.92%
3 Year Est. Return
+160.27%
5 Year Est. Return
+179.96%
10 Year Est. Return
AUM
$2.58B
AUM Growth
+$791M
Cap. Flow
+$834M
Cap. Flow %
32.29%
Top 10 Hldgs %
53.37%
Holding
2,471
New
1,056
Increased
297
Reduced
248
Closed
869

Top Sells

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$51.5M
2
AMZN icon
Amazon
AMZN
+$42.5M
3
MSFT icon
Microsoft
MSFT
+$31.2M
4
UNH icon
UnitedHealth
UNH
+$25.7M
5
ZG icon
Zillow
ZG
+$21.9M

Sector Composition

Rank Sector Weight
1 Miscellaneous 30.04%
2 Communication Services 27.64%
3 Financials 13.64%
4 Technology 7.34%
5 Healthcare 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QH
1451
Quhuo Ltd
QH
$10.7M
$18K ﹤0.01%
+17,108
New +$52.2K
SMSI icon
1452
Smith Micro Software
SMSI
$14.7M
$18K ﹤0.01%
+6,805
New +$22.3K
MEDS
1453
DataMeds AI
MEDS
$12.4M
$18K ﹤0.01%
+897
New +$26.3K
BMR icon
1454
Beamr Imaging
BMR
$20M
$17K ﹤0.01%
+10,889
New +$25.9K
CLGN icon
1455
CollPlant Biotechnologies
CLGN
$8.7M
$17K ﹤0.01%
+1,181
New +$24.2K
HCTI icon
1456
Healthcare Triangle
HCTI
$11.1M
$17K ﹤0.01%
+447
New +$62.1K
ASTLW icon
1457
Algoma Steel Group Warrant
ASTLW
$150K
$16K ﹤0.01%
185,248
+141,910
+327% +$23.4K
GNLN icon
1458
Greenlane Holdings
GNLN
$1.72M
$16K ﹤0.01%
+1,269
New +$32.2K
PMVP icon
1459
PMV Pharmaceuticals
PMVP
$80.2M
$16K ﹤0.01%
+12,842
New +$17.2K
XTNT icon
1460
Xtant Medical Holdings
XTNT
$45.6M
$16K ﹤0.01%
20,146
-11,518
-36% -$8.37K
MKDW
1461
MKDWELL Tech Inc
MKDW
$95.4M
$16K ﹤0.01%
3,384
+1,081
+47% +$6.43K
RNTX
1462
Rein Therapeutics
RNTX
$68.6M
$16K ﹤0.01%
+13,663
New +$18.8K
EVOXW
1463
Evolution Global Acquisition Corp Warrants
EVOXW
$16K ﹤0.01%
+42,282
New +$16.1K
ALXO icon
1464
ALX Oncology
ALXO
$235M
$15K ﹤0.01%
+13,702
New +$20.7K
CTM icon
1465
Castellum
CTM
$59.1M
$15K ﹤0.01%
+16,804
New +$17.9K
GTEC icon
1466
Greenland Technologies Holding
GTEC
$28.9M
$15K ﹤0.01%
+23,977
New +$26.4K
REE
1467
DELISTED
REE Automotive
REE
$15K ﹤0.01%
+19,923
New +$17.6K
RFL icon
1468
Rafael Holdings
RFL
$102M
$15K ﹤0.01%
+12,820
New +$16.6K
TNON icon
1469
Tenon Medical
TNON
$2.7M
$15K ﹤0.01%
+436
New +$17.5K
TRNR icon
1470
Interactive Strength
TRNR
$3.92M
$15K ﹤0.01%
+244
New +$40.9K
VERO
1471
DELISTED
Venus Concept
VERO
$15K ﹤0.01%
+10,442
New +$21.2K
YARW
1472
Yarrow Bioscience
YARW
$79.9M
$15K ﹤0.01%
+507
New +$10.2K
DEVS
1473
DELISTED
DevvStream Corp
DEVS
$15K ﹤0.01%
+10,876
New +$20K
YHC
1474
LQR House Inc
YHC
$1.75M
$15K ﹤0.01%
+170
New +$14.8K
ADIL
1475
Adial Pharmaceuticals
ADIL
$13.7M
$14K ﹤0.01%
+2,553
New +$20.7K

Similar funds

Virtu Financial's Q4 2025 Portfolio in Review

As of Q4 2025, Virtu Financial held 2,471 positions worth $2.58B, up 44% from $1.79B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Virtu Financial deployed $834M of net new capital in Q4 2025, opening 1,056 new positions and adding to 297 existing holdings. Its largest new stake was SPDR Gold Trust: 1,198,436 shares worth $475M.

By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 19% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $51.5M trimmed.

  • Virtu Financial's largest Q4 2025 buy was SPDR Gold Trust: 1,198,436 shares worth $475M.
  • Virtu Financial added most to Alphabet (Google) Class A in Q4 2025, an estimated $518M increase.
  • Virtu Financial's biggest Q4 2025 reduction was Berkshire Hathaway Class A, cutting an estimated $51.5M.
  • Virtu Financial fully exited Amazon in Q4 2025, selling an estimated $42.5M.
  • Virtu Financial's ten largest holdings make up 53% of its $2.58B portfolio in Q4 2025.
  • Virtu Financial opened 1,056 new positions and closed 869 in Q4 2025.
  • Virtu Financial's portfolio value rose 44% quarter-over-quarter to $2.58B.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.